The past twenty years have witnessed a dramatic expansion in the capacity of developing nations to conduct basic research and to apply that research to solving such critical issues as food security, public health, and environmental protection. As a result, important steps have been taken on the road to curbing poverty and promoting human development.
A key challenge faced by developing countries in trying to conduct basic research has resided in building basic scientific capacity. That has meant providing adequate funding for education and training and for constructing laboratories that could fulfill the needs of faculty and students alike. Today, these challenges remain stubbornly in place in many developing nations. Nevertheless, more and more developing countries have passed a threshold of basic competency and are now seeking to strengthen and broaden what has become a firm foundation in research.
Rising Optimism
There are a number of key success stories in the developing world. China has built a formidable infrastructure in the life sciences in just two decades, demonstrating growing capabilities in bioinformatics, genomics, and stem cell research. In 1986, for example, China launched the National High Technology R&D Program. By 2001, the program was providing funding for some 20,000 researchers and administrative staff in more than 3,000 research institutions (http://www.oti.globalwatchonline. com/online_pdfs/36206MR.pdf ).
India has developed a profitable pharmaceutical industry that has manufactured an impressive list of recombinant vaccines against polio, rabies, hepatitis B, and typhoid (Kumar et al., 2004) . Brazil is focusing its efforts on training young scientists and on applying its growing expertise in the life sciences both to take advantage of its unmatched biodiversity and to become a world leader in biofuels (TWAS Newsletter, 2006) . The number of articles published by Argentinean scientists in peer-reviewed international journals continues to increase, and the nation has taken a global leadership position in cultivating genetically modified (GM) crops (Roca et al., 2004) . Malaysia has efficiently raised its skill levels in the life sciences and is now seeking to build a vibrant commercial sector in the fields of biotechnology and genetic engineering (Shah, 2006) . South Africa has emerged as the primary center of research and development in the life sciences in Africa (Motari et al., 2004) . Cuba is a leading developing nation in the life sciences, earning an international reputation for the development and manufacture of vaccines . The emphasis that these countries have placed in developing life sciences research demonstrates a clear "take home" message that scientific competency is difficult to displace once it has taken root.
The welcome change in the scientific competence of certain developing countries can also be seen in the increasing number of universities and research institutes that have created or expanded departments in biology and related fields such as bioinformatics and genetic engineering. Brazil This change in scientific competence is also visible in the small but steadily increasing number of private firms that are engaged in selling agricultural and health-related biotechnology products and services both within their own countries and abroad. In 1993, Brazil was home to 76 biotechnology firms; by 2004, the Brazilian Association of Biotechnology estimated the number of core biotechnology firms to be 150; other sources have placed the number at more than 300 (Niosi and Reid, 2007) . The number of biotechnology firms in China is estimated to be ~130 (Ernst and Young, 2004 )-some state-owned commercial enterprises, others small private firms-and they benefit from a huge population that allows for domestic clinical assays and a large pool of students who have often been trained overseas but increasingly are returning home to pursue their careers (Louet, 2004 ). India's 350 plus private firms are aggressively seeking to move up the innovation ladder from companies that manufacture inexpensive generic versions of existing pharmaceuticals to companies creating new high-value products (BioSpectrum India, 2007) . Shantha Biotechnics is the first company in India to produce a recombinant DNA hepatitis B vaccine; this vaccine has been prequalified by the World Health Organization and is being supplied to United Nations agencies for distribution in poor countries. This home-grown company also created India's first 4-in-1 vaccine against diphtheria, tetanus, pertussis, and hepatitis (Frew et al., 2007) . Cuba, home to some of the best life science research centers in the developing world, has created "commercial" divisions in its state-owned institutions for the sale of vaccines to combat meningitis B, hepatitis B, and pneumonia .
Another visible display of the change in scientific competence and the willingness to embrace scientific advances lies in the cultivation of GM crops. Since the US Food and Drug Administration licensed the world's first GM crop, Flavr Savr tomato, in 1994, the amount of farmland devoted to GM crops worldwide has doubled each year and now exceeds 100 million hectares. More than 10 million farmers in 22 countries grow GM crops, and more than 40% of the agricultural land devoted to GM crops is in the developing world (James, 2006) . Argentina is second only to the United States in hectares cultivated with GM crops; Brazil is third. Last year, India supplanted China as number four on the list. Paraguay, South Africa, Uruguay, and the Philippines are each in the top 10. All told, half of the 22 countries that grow GM crops are developing nations.
Mind the Gaps
The North-South capacity gap in the life sciences continues to narrow, but it has by no means disappeared. At the same time, a new gap in capacity has emerged between scientifically proficient developing countries and scientifically lagging developing countries-the so-called South-South gap. This divide has surfaced because the number of developing countries making significant strides in building scientific capacity remains small (Argentina, Brazil, Chile, China, Cuba, India, Malaysia, Mexico, and South Africa). Meanwhile, the number of countries that have not made significant strides is large and includes most of the countries in sub-Saharan Africa and countries with predominantly Muslim populations. However, there are examples of increasing SouthSouth cooperation that are helping to close this gap, exemplified by China's $5 billion Development Fund for Africa and Brazil's Pro-Africa Program that funds science and technology projects in sub-Saharan Africa (Hassan, 2007) . There is also an increase in the number of postgraduates and postdoctoral fellows moving from one part of the Southern hemisphere to another to obtain further training (see Figure 1 ).
There are, as well, valiant efforts within Africa to forge new levels of cooperation on science and technology. In 2003, the first ministerial meeting of the New Partnership for Africa's Development (NEPAD) called for Africa's leaders to seek a common position on biotechnol- ogy (Mugabe, 2003; Panos, 2005; Thompson, 2004) . In 2005, the African Union (AU) established a 14-member high-level group, cochaired by Calestous Juma, director, Science, Technology and Globalization, Harvard University, and Ismail Serageldin, director, Bibliotheca Alexandria in Egypt, to advise AU members on how advances in biotechnology would affect agriculture, health, and the environment in Africa (Chege, 2005 (Juma and Serageldin, 2007) . This public debate is good for science in general and the life sciences in particular and is emblematic of the public's increasing interest in science in Africa.
At the annual AU summit meeting this year, African leaders pledged to establish national and regional centers of excellence in science and technology and to allocate at least 1% of their gross domestic product (GDP) to research and development by 2020. Indeed, a number of African nations have already increased expenditure on science. For example, Rwanda has increased science spending to 1.6% GDP and South Africa plans to raise R&D spending to 1% of GDP by 2009 (Hassan, 2007 . Modeled after the Indian Institutes of Technology spread across the Indian subcontinent, the planned African Institute of Science and Technology (AIST) will consist of several higher education campuses across sub-Saharan Africa. The first AIST campus is under construction in Abuja, Nigeria and will open its doors to students in September 2008.
These recent measures indicate that Africa is increasingly determined to control its own destiny in both the development and application of life sciences. For example, there are efforts to develop pharmaceuticals based on knowledge of indigenous and medicinal plants.
These initiatives speak well for the future of science across the continent, making science in Africa more relevant to society and more accountable.
Public and Private Affairs
Even developing countries that have successfully strengthened their scientific capacity have proven more adept at building their knowledge base than at applying the knowledge that their scientists acquire to address societal concerns. The most critical shortfall in these efforts has been an inability to forge strong links between universities/research institutes, largely funded by governments, and the private sector, which is admittedly weak in most developing countries. For example, experts estimate that more than 60% of global research and development in biotechnology is funded by the private sector (Charlafti, 2003) . Yet, even among the most advanced developing countries, the private sector has made only marginal contributions to such efforts, which remain almost exclusively funded by national governments.
To gain parity with the developed world, developing countries will need to strengthen and stimulate the private sector and then encourage the creation of durable partnerships between government, research institutes, and nascent private companies. This is beginning to take place in several countries, notably Brazil, China, India, and, to a lesser extent, Malaysia and South Africa. But the pace of reform must quicken if the capacity gap between the North and South is to close at a more rapid and even pace.
Science and Society
Scientists in both developed and developing countries should not be shy about speaking out against viewpoints that they feel ignore scientific truths. Rather than viewing public discussions as fruitless distractions, scientists should welcome such engagements as opportunities to speak out about the importance of their work beyond the familiar boundaries of the scientific community. As the life sciences continue to become stronger in developing countries and as applications of the ever-expanding knowledge base gain greater presence across the South, the dialog between the scientific community and society will no doubt intensify, and scientists should be prepared. National, merit-based science academies represent an often-neglected but potentially significant set of institutions that could play a vital role in helping to build capacity in the life sciences in developing countries and in bridging the science-society gap in the biological sciences. The public often thinks of these institutions as places where eminent scientists politely exchange ideas and socialize at a leisurely gentlemanly pace. But science academies are also places of extraordinary scientific talent and expertise. They have only recently begun to change their ways, seeking to make the storehouse of knowledge that their members possess more accessible and useful to society.
Science academies could ultimately serve as responsible intermediaries between science and society-knowledge-based brokers for the public good-that would help to explain the complexities of the life sciences to lay citizens while simultaneously forging useful links between the scientific community and the public. Giving independent, unbiased advice to governments on science-based issues of critical importance to society may prove to be the most significant contribution that science academies can make.
It is clear that in the minds of many political leaders in the South, the life sciences in general and biotechnology in particular are on par with information and communication technologies, representing a truly transformational knowledge base that serves a fundamental role in national efforts to build successful societies capable of competing in today's global economy. A key issue that concerns both devel-oped and developing nations alike is the capacity to know, learn, and apply the world's growing scientific expertise in wise, productive, and safe ways. This is especially true in the life sciences where advances in research and technology are likely to shape and reshape our world in untold ways in the years ahead.
